Press Release
Basel, December 3, 2009 - Novartis announced today that the European Commission (EC) has approved Onbrez Breezhaler (QAB149 or indacaterol) in both 150 mcg and 300 mcg doses as a new once-d...
PharmiWeb,
Thu Dec 03 01:40:06 PST 2009
• Found on Yahoo! News
What Is Cushing's Syndrome? What Causes Cushing's Syndrome?
Cushing's syndrome, or Cushing syndrome is a collection of signs and symptoms caused by too much cortisol hormone. It is a very complex hormonal condition which affects many parts of the bo...
Medical News Today,
Wed Dec 02 10:40:07 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
Tacio: Understanding osteoporosis
Health 101 read more
Sun Star,
Mon Nov 30 06:51:20 PST 2009
• Found on Yahoo! News
Eurand Launches ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules
First and Only FDA-Approved Pancreatic Enzyme Product Clinically Proven in Patients as Young as One Year Old
Marketwire,
Mon Nov 30 04:03:46 PST 2009
• Found on Yahoo! News
Eurand Launches ZENPEP(TM) (Pancrelipase) Delayed-Release Capsules
PHILADELPHIA, PA--(Marketwire - 11/30/09) - Eurand N.V. (NASDAQ: EURX - News ), a global specialty pharmaceutical company, today announced the commercial availability of ZENPEP(TM) (pancrel...
Marketwire via Yahoo! Finance,
Mon Nov 30 04:00:00 PST 2009
• Found on Yahoo! News